ABSTRACT
OBJECTIVE: To study the dynamics of neurological and emotional disturbances in patients with dorsopathy treated with cytoflavin. MATERIAL AND METHODS: We examined 120 patients aged from 21 to 55 years, mean age 38±9 years. All patients received nonsteroid anti-inflammatory drugs, myorelaxants, vitamins. The main group comprised 67 patients who received cytoflavin (10ml of the solution in one injection once a day in 200 ml of isotonic solution of sodium chloride intravenously in drops in the morning during 10 days) in addition to standard treatment. The comparison group included 53 patients who received standard treatment during 10 days. RESULTS AND CONCLUSION: The use of cytoflavin allowed earlier arresting of the pain syndrome, restored the disturbed sensitivity, improved emotional status and decreased the severity of a neuropathic pain component.
Subject(s)
Affective Symptoms/diagnosis , Flavin Mononucleotide/therapeutic use , Inosine Diphosphate/therapeutic use , Low Back Pain/drug therapy , Niacinamide/therapeutic use , Succinates/therapeutic use , Succinic Acid/therapeutic use , Adult , Affective Symptoms/etiology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Drug Combinations , Female , Humans , Low Back Pain/complications , Low Back Pain/physiopathology , Male , Middle Aged , Neuromuscular Agents/therapeutic use , Young AdultABSTRACT
Efficacy of mexidol in the complex treatment of lumbosacral radiculopathy has been analyzed. Comparing to the traditional treatment using clinical and immunological methods, this method proved to be superior.
